PIM-1 kinase inhibitor SMI-4a exerts antitumor effects in chronic myeloid leukemia cells by enhancing the activity of glycogen synthase kinase 3β

Por Fan, Rui-Fang, Lu, Ying, Fang, Zhi-Gang, Guo, Xiao-Yan, Chen, Yu-Xin, Xu, Yi-Chuan, Lei, Ya-Mei, Liu, Ke-Fang, Lin, Dong-Jun, Liu, Ling-Ling, Liu, Xiang-Fu
Publicado no Mol Med Rep (2017)